Repacking of the transmembrane domains of P-glycoprotein during the transport ATPase cycle

被引:253
作者
Rosenberg, MF
Velarde, G
Ford, RC
Martin, C
Berridge, G
Kerr, ID
Callaghan, R
Schmidlin, A
Wooding, C
Linton, KJ
Higgins, CF
机构
[1] Imperial Coll Sch Med, MRC, Ctr Clin Sci, London W12 0NN, England
[2] Univ Manchester, Dept Biomol Sci, Manchester M60 1QD, Lancs, England
[3] Univ Oxford, John Radcliffe Hosp, Dept Clin Lab Sci, Oxford OX3 9DU, England
基金
英国惠康基金;
关键词
ABC transporters; membrane protein structure; multidrug resistance; two-dimensional crystals;
D O I
10.1093/emboj/20.20.5615
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
P-glycoprotein (P-gp) is an ABC (ATP-binding cassette) transporter, which hydrolyses ATP and extrudes cytotoxic drugs from mammalian cells. P-gp consists of two transmembrane domains (TMDs) that span the membrane multiple times, and two cytoplasmic nucleotide-binding domains (NBDs). We have determined projection structures of P-gp trapped at different steps of the transport cycle and correlated these structures with function. In the absence of nucleotide, an similar to 10 Angstrom resolution structure was determined by electron cryo-microscopy of two-dimensional crystals. The TMDs form a chamber within the membrane that appears to be open to the extracellular milieu, and may also be accessible from the lipid phase at the interfaces between the two TMDs. Nucleotide binding causes a repacking of the TMDs and reduction in drug binding affinity. Thus, ATP binding, not hydrolysis, drives the major conformational. change associated with solute translocation. A third distinct conformation of the protein was observed in the post-hydrolytic transition state prior to release of ADP/P-i. Biochemical data suggest that these rearrangements may involve rotation of transmembrane alpha -helices. A mechanism for transport is suggested.
引用
收藏
页码:5615 / 5625
页数:11
相关论文
共 53 条
[1]   Biochemical, cellular, and pharmacological aspects of the multidrug transporter [J].
Ambudkar, SV ;
Dey, S ;
Hrycyna, CA ;
Ramachandra, M ;
Pastan, I ;
Gottesman, MM .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1999, 39 :361-398
[2]   3-DIMENSIONAL STRUCTURE DETERMINATION BY ELECTRON-MICROSCOPY OF TWO-DIMENSIONAL CRYSTALS [J].
AMOS, LA ;
HENDERSON, R ;
UNWIN, PNT .
PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY, 1983, 39 (03) :183-231
[3]   Surface crystallisation of the plasma membrane H+-ATPase on a carbon support film for electron crystallography [J].
Auer, M ;
Scarborough, GA ;
Kühlbrandt, W .
JOURNAL OF MOLECULAR BIOLOGY, 1999, 287 (05) :961-968
[4]   Three-dimensional map of the plasma membrane H+-ATPase in the open conformation [J].
Auer, M ;
Scarborough, GA ;
Kühlbrandt, W .
NATURE, 1998, 392 (6678) :840-843
[5]   THE CCP4 SUITE - PROGRAMS FOR PROTEIN CRYSTALLOGRAPHY [J].
BAILEY, S .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1994, 50 :760-763
[6]   Cysteine-scanning mutagenesis provides no evidence for the extracellular accessibility of the nucleotide-binding domains of the multidrug resistance transporter P-glycoprotein [J].
Blott, EJ ;
Higgins, CF ;
Linton, KJ .
EMBO JOURNAL, 1999, 18 (23) :6800-6808
[7]   Multidrug resistance in Lactococcus lactis: Evidence for ATP-dependent drug extrusion from the inner leaflet of the cytoplasmic membrane [J].
Bolhuis, H ;
vanVeen, HW ;
Molenaar, D ;
Poolman, B ;
Driessen, AJM ;
Konings, WN .
EMBO JOURNAL, 1996, 15 (16) :4239-4245
[8]   The cytochrome b6f complex:: structural studies and comparison with the bc1 complex [J].
Breyton, C .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS, 2000, 1459 (2-3) :467-474
[9]   The functional purification of P-glycoprotein is dependent on maintenance of a lipid-protein interface [J].
Callaghan, R ;
Berridge, G ;
Ferry, DR ;
Higgins, CF .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 1997, 1328 (02) :109-124
[10]   Atomic scale movement of the voltage-sensing region in a potassium channel measured via spectroscopy [J].
Cha, A ;
Snyder, GE ;
Selvin, PR ;
Bezanilla, F .
NATURE, 1999, 402 (6763) :809-813